BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12381298)

  • 1. Modulating calmodulin binding specificity through computational protein design.
    Shifman JM; Mayo SL
    J Mol Biol; 2002 Oct; 323(3):417-23. PubMed ID: 12381298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the origins of binding specificity through the computational redesign of calmodulin.
    Shifman JM; Mayo SL
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13274-9. PubMed ID: 14597710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational design of calmodulin mutants with up to 900-fold increase in binding specificity.
    Yosef E; Politi R; Choi MH; Shifman JM
    J Mol Biol; 2009 Feb; 385(5):1470-80. PubMed ID: 18845160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of new binding specificity by simultaneous mutagenesis of calmodulin and a target peptide.
    Green DF; Dennis AT; Fam PS; Tidor B; Jasanoff A
    Biochemistry; 2006 Oct; 45(41):12547-59. PubMed ID: 17029410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable conformation and dynamics of calmodulin complexed with peptides derived from the autoinhibitory domains of target proteins.
    Yao Y; Squier TC
    Biochemistry; 1996 May; 35(21):6815-27. PubMed ID: 8639633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-molecule force spectroscopy distinguishes target binding modes of calmodulin.
    Junker JP; Rief M
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14361-6. PubMed ID: 19667195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of domain 3 of calmodulin in activation of calmodulin-stimulated phosphodiesterase and smooth muscle myosin light chain kinase.
    Su Z; Fan D; George SE
    J Biol Chem; 1994 Jun; 269(24):16761-5. PubMed ID: 8206999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the high affinity and low sequence specificity of calmodulin binding to its targets.
    Afshar M; Caves LS; Guimard L; Hubbard RE; Calas B; Grassy G; Haiech J
    J Mol Biol; 1994 Dec; 244(5):554-71. PubMed ID: 7990140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of amino acids essential for calmodulin binding and activation of smooth muscle myosin light chain kinase.
    Bagchi IC; Huang QH; Means AR
    J Biol Chem; 1992 Feb; 267(5):3024-9. PubMed ID: 1737757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MgATP-binding site on chicken gizzard myosin light chain kinase remains open and functionally competent during the calmodulin-dependent activation-inactivation cycle of the enzyme.
    Kennelly PJ; Leng J; Marchand P
    Biochemistry; 1992 Jun; 31(23):5394-9. PubMed ID: 1606165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further insights into calmodulin-myosin light chain kinase interaction from solution scattering and shape restoration.
    Heller WT; Krueger JK; Trewhella J
    Biochemistry; 2003 Sep; 42(36):10579-88. PubMed ID: 12962481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ATCUN domain as a probe of intermolecular interactions: application to calmodulin-peptide complexes.
    Mal TK; Ikura M; Kay LE
    J Am Chem Soc; 2002 Nov; 124(47):14002-3. PubMed ID: 12440892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the complex of calmodulin with the target sequence of calmodulin-dependent protein kinase I: studies of the kinase activation mechanism.
    Clapperton JA; Martin SR; Smerdon SJ; Gamblin SJ; Bayley PM
    Biochemistry; 2002 Dec; 41(50):14669-79. PubMed ID: 12475216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin binding to myosin light chain kinase begins at substoichiometric Ca2+ concentrations: a small-angle scattering study of binding and conformational transitions.
    Krueger JK; Bishop NA; Blumenthal DK; Zhi G; Beckingham K; Stull JT; Trewhella J
    Biochemistry; 1998 Dec; 37(51):17810-7. PubMed ID: 9922147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calmodulin kinase II chimeras used to investigate the structural requirements for smooth muscle myosin light chain kinase autoinhibition and calmodulin-dependent activation.
    Chin D; Schreiber JL; Means AR
    Biochemistry; 1999 Nov; 38(46):15061-9. PubMed ID: 10563788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin.
    Findlay WA; Gradwell MJ; Bayley PM
    Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence analysis of calmodulin mutants containing tryptophan: conformational changes induced by calmodulin-binding peptides from myosin light chain kinase and protein kinase II.
    Chabbert M; Lukas TJ; Watterson DM; Axelsen PH; Prendergast FG
    Biochemistry; 1991 Jul; 30(30):7615-30. PubMed ID: 1854758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
    Bagchi IC; Kemp BE; Means AR
    Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic delineation of a calmodulin peptide interaction.
    Hultschig C; Hecht HJ; Frank R
    J Mol Biol; 2004 Oct; 343(3):559-68. PubMed ID: 15465045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.